Philippines Health News API

{
    "totalArticles": 2511190,
    "articles": [
        {
            "id": "221ae07574ca1e310c1868b500714425",
            "title": "Prenatal Exposure to Pesticide Linked to Brain Abnormalities",
            "description": "Higher prenatal exposure to the common pesticide chlorpyrifos is linked to significant changes in brain structure and function and poorer motor function in children.",
            "content": "Higher prenatalexposure to a common pesticide, chlorpyrifos (CPF), was associated with a greater likelihood of brain abnormalities and poorer motor function among children aged 6 to almost 15 years in a prospective, longitudinal study.\nMRIs revealed ... [7149 chars]",
            "url": "https://www.medscape.com/viewarticle/prenatal-exposure-common-pesticide-linked-brain-2025a1000lw0",
            "image": "https://img.medscapestatic.com/vim/live/professional_assets/medscape/images/thumbnail_library/dt-250819-chlorpyrifos-800x450.jpg",
            "publishedAt": "2025-08-19T13:05:30Z",
            "lang": "en",
            "source": {
                "id": "12e9520678d529ebd117a729c691e314",
                "name": "Medscape",
                "url": "https://www.medscape.com",
                "country": "ph"
            }
        },
        {
            "id": "503b89b1574e89a5776dcc75dcdfcf04",
            "title": "Improvement in Physical Function Associated With Burosumab in a Patient With X-linked Hypophosphatemia: A Case Report",
            "description": "Burosumab, a human immunoglobulin G1 monoclonal antibody that targets fibroblast growth factor 23 (FGF23), was developed to treat X-linked hypophosphatemic rickets/osteomalacia (XLH). By binding to FGF23, burosumab promotes the reabsorption of phosphorus from the kidney, increases the production of active vitamin D, and promotes the intestinal absorption of phosphorus and calcium. Herein, we report a one-year evaluation of physical function in adult patients with XLH who were treated using burosumab. A 40-year-old male patient with a history of lower limb varus deformity was diagnosed with vitamin D-resistant rickets in early childhood. Around October 2021, the patient began experiencing pain in both lower limbs when ascending and descending stairs at his place of work, making it difficult for him to perform his duties. We prescribed subcutaneous burosumab (70 mg) in December 2022. Twelve weeks after starting this treatment, his 10-meter walking speed and Time Up-and-Go Test results showed significant improvement. We therefore concluded that burosumab treatment may improve physical function in adult patients with XLH.",
            "content": "Please choose I'm not a medical professional. Allergy and Immunology Anatomy Anesthesiology Biostatistics Cardiac/Thoracic/Vascular Surgery Cardiology Critical Care Dentistry Dermatology Diabetes and Endocrinology Emergency Medicine Epidemiology and ... [1093 chars]",
            "url": "https://www.cureus.com/articles/367297-improvement-in-physical-function-associated-with-burosumab-in-a-patient-with-x-linked-hypophosphatemia-a-case-report",
            "image": "https://assets.cureus.com/uploads/figure/file/1502431/article_river_c41962c0767311f09dd7d959d6806677-Figure-1.png",
            "publishedAt": "2025-08-19T12:50:57Z",
            "lang": "en",
            "source": {
                "id": "0a55ec8679d71c09d38ea90a05731eda",
                "name": "Cureus",
                "url": "https://www.cureus.com",
                "country": "ph"
            }
        },
        {
            "id": "9e38393b73f3977ac278b6768204ab96",
            "title": "Bubonic Plague Bowled Over by Oral Antibiotics",
            "description": "A 10-day oral ciprofloxacin regimen proves as effective as injectable antibiotics for bubonic plague, offering a simpler option in low-resource settings.",
            "content": "Researchers in Madagascar have reported the first randomised controlled trial for the treatment of bubonic plague. Published in The New England Journal of Medicine, the study found that “oral ciprofloxacin monotherapy for 10 days was non-inferior to ... [4427 chars]",
            "url": "https://www.medscape.com/viewarticle/bubonic-plague-bowled-over-oral-antibiotics-2025a1000lvt",
            "image": "https://img.medscapestatic.com/vim/live/professional_assets/medscape/images/thumbnail_library/is_220324_antibiotics_800x450.jpg",
            "publishedAt": "2025-08-19T12:37:34Z",
            "lang": "en",
            "source": {
                "id": "12e9520678d529ebd117a729c691e314",
                "name": "Medscape",
                "url": "https://www.medscape.com",
                "country": "ph"
            }
        }
    ]
}